Regulation of Exit from Quiescence by p27 and Cyclin D1-CDK4

REFERENCES

• Aktas, H., H. Cai, and G. M. Cooper 1997. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. Mol. Cell. Biol. 17: 3850–3857.
   PubMed Web of Science ®Google Scholar
• Albanese, C., J. Johnson, G. Watanabe, N. Eklund, D. Vu, A. Arnold, and R. G. Pestell 1995. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270: 23589–23597.
   PubMed Web of Science ®Google Scholar
• Alessandrini, A., D. S. Chiaur, and M. Pagano 1997. Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation. Leukemia 11: 342–345.
   PubMedGoogle Scholar
• Baldin, V., J. Lukas, M. J. Marcote, M. Pagano, and G. Draetta 1993. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7: 812–821.
   PubMed Web of Science ®Google Scholar
• Barbacid, M. 1987. ras genes. Annu. Rev. Biochem. 56: 779–827.
   PubMed Web of Science ®Google Scholar
• Bos, J. L. 1989. ras oncogenes in human cancer: a review. Cancer Res. 49: 4682–4689.
   PubMed Web of Science ®Google Scholar
• Brunet, A., G. Pages, and J. Pouysségur 1994. Constitutive active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts. Oncogene 9: 3379–3387.
   PubMed Web of Science ®Google Scholar
• Cai, H., J. Szeberenyi, and G. M. Cooper 1990. Effect of a dominant inhibitory Ha-ras mutation on mitogenic signal transduction in NIH 3T3 cells. Mol. Cell. Biol. 10: 5314–5323.
   PubMed Web of Science ®Google Scholar
• Chen, J., P. Saha, S. Kornbluth, B. D. Dynlacht, and A. Dutta 1996. Cyclin-binding motifs are essential to the function of p21CIP1. Mol. Cell. Biol. 16: 4673–4682.
   PubMed Web of Science ®Google Scholar
• Cheng, M., V. Sexl, C. J. Sherr, and M. F. Roussel 1998. Assembly of cyclin D-dependent kinase and titration of p27Kip1 by mitogen-activated protein kinase kinase (MEK1). Proc. Natl. Acad. Sci. USA 95: 1091–1096.
   PubMed Web of Science ®Google Scholar
• Clurman, B. E., R. J. Sheaff, K. Thress, M. Groudine, and J. M. Roberts 1996. Turnover of cyclin E by the ubiquitin-proteosome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev. 10: 1979–1990.
   PubMed Web of Science ®Google Scholar
• Coats, S., W. M. Flanagan, M. Nourse, and J. M. Roberts 1996. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 272: 877–880.
   PubMed Web of Science ®Google Scholar
• Connell-Crowley, L., S. J. Elledge, and W. J. Harper 1998. G1 cyclin-dependent kinases are sufficient to initiate DNA synthesis in quiescent human fibroblasts. Curr. Biol. 8: 65–68.
   PubMed Web of Science ®Google Scholar
• Cowley, S., H. Paterson, P. Kemp, and C. J. Marshall 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77: 841–852.
   PubMed Web of Science ®Google Scholar
• de Vries-Smits, A. M. M., B. M. T. Burgering, S. J. Leevers, C. J. Marshall, and J. L. Bos 1992. Involvement of p21ras in activation of extracellular signal-regulated kinase 2. Nature 357: 602–604.
   PubMedGoogle Scholar
• Dobrowolski, S., M. Harter, and D. W. Stacey 1994. Cellular ras activity is required for passage through multiple points of the G0/G1 phase in BALB/c 3T3 cells. Mol. Cell. Biol. 14: 5441–5449.
   PubMedGoogle Scholar
• Ewen, M. E., H. K. Sluss, C. J. Sherr, H. Matsushime, J.-Y. Kato, and D. M. Livingston 1993. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73: 487–497.
   PubMed Web of Science ®Google Scholar
• Feig, L. A., and G. M. Cooper 1988. Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol. Cell. Biol. 8: 3235–3243.
   PubMed Web of Science ®Google Scholar
• Feramisco, J. R., M. Gross, T. Kamata, M. Rosenberg, and R. W. Sweet 1984. Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells. Cell 38: 109–117.
   PubMed Web of Science ®Google Scholar
• Filmus, J., A. I. Robles, W. Shi, M. J. Wong, L. L. Colombo, and C. J. Conti 1994. Induction of cyclin D1 overexpression by activated ras. Oncogene 9: 3627–3633.
   PubMed Web of Science ®Google Scholar
• Firpo, E. J., A. Koff, M. J. Solomon, and J. M. Roberts 1994. Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol. Cell. Biol. 14: 4889–4901.
   PubMed Web of Science ®Google Scholar
• Geng, Y., E. N. Eaton, M. Picon, J. M. Roberts, A. S. Lundberg, A. Gifford, C. Sardet, and R. A. Weinberg 1996. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene 16: 2402–2407.
   Google Scholar
• Hall, M., and G. Peters 1996. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv. Cancer Res. 68: 67–108.
   PubMed Web of Science ®Google Scholar
• Hengst, L., V. Dulic, J. M. Slingerland, E. Lees, and S. I. Reed 1994. A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc. Natl. Acad. Sci. USA 91: 5291–5295.
   PubMed Web of Science ®Google Scholar
• Herber, B., M. Truss, M. Beato, and R. Muller 1994. Inducible regulatory elements in the human cyclin D1 promoter. Oncogene 9: 1295–1304.
   PubMed Web of Science ®Google Scholar
• Herrera, R. E., V. P. Sah, B. O. Williams, T. P. Makela, R. A. Weinberg, and T. Jacks 1996. Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts. Mol. Cell. Biol. 16: 2402–2407.
   PubMedGoogle Scholar
• Joneson, T., M. A. White, M. H. Wigler, and D. Bar-Sagi 1996. Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of RAS. Science 271: 810–812.
   PubMed Web of Science ®Google Scholar
• Kato, J.-Y., M. Matsuoka, K. Polyak, J. Massague, and C. J. Sherr 1994. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell 79: 487–496.
   PubMed Web of Science ®Google Scholar
• Kato, J.-Y., M. Matsuoka, D. K. Strom, and C. J. Sherr 1994. Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase. Mol. Cell. Biol. 14: 2713–2721.
   PubMed Web of Science ®Google Scholar
• Kato, J.-Y., H. Matsushime, S. W. Hiebert, M. E. Ewen, and C. J. Sherr 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase cdk4. Genes Dev. 7: 331–342.
   PubMed Web of Science ®Google Scholar
• Kawada, M., S. Yamagoe, Y. Murakami, K. Suzuki, S. Mizuno, and Y. Uehara 1997. Induction of p27Kip1 degradation and anchorage independence through the MAP kinase signaling pathway. Oncogene 15: 629–637.
   PubMed Web of Science ®Google Scholar
• Koff, A., M. Ohtsuki, K. Polyak, J. M. Roberts, and J. Massagué 1993. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science 260: 536–539.
   PubMed Web of Science ®Google Scholar
• Kolch, W., G. Heidecker, P. Lloyd, and U. R. Rapp 1991. Raf-1 protein kinase is required for growth of induced NIH/3T3 cells. Nature 12: 426–428.
   Google Scholar
• Krude, T., M. Jackman, J. Pines, and R. A. Lasky 1997. Cyclin/Cdk-dependent initiation of DNA replication in a human cell-free system. Cell 88: 109–119.
   PubMed Web of Science ®Google Scholar
• LaBaer, J., M. D. Garrett, L. F. Stevenson, J. M. Slingerland, C. Sandhu, H. S. Chou, A. Fattaey, and E. Harlow 1997. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11: 847–862.
   PubMed Web of Science ®Google Scholar
• Lavoie, J. N., G. L’Allemain, A. Brunet, R. Muller, and J. Pouysségur 1996. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271: 20608–20616.
   PubMed Web of Science ®Google Scholar
• Leng, X., L. Connell-Crowley, D. Goodrich, and J. W. Harper 1997. S-phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation. Curr. Biol. 7: 709–712.
   PubMed Web of Science ®Google Scholar
• Leone, G., J. DeGregori, R. Sears, L. Jakoi, and J. R. Nevins 1997. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature 387: 422–426.
   PubMed Web of Science ®Google Scholar
• Li, Y., C. W. Jenkins, M. A. Nichols, and Y. Xiong 1994. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 9: 2261–2268.
   PubMed Web of Science ®Google Scholar
• Liu, J.-J., J.-R. Chao, M.-C. Jiang, S.-Y. Ng, J. J.-Y. Yen, and H. F. Yang-Yen 1995. Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells. Mol. Cell. Biol. 15: 3654–3663.
   PubMed Web of Science ®Google Scholar
• Loda, M., B. Cukor, S. W. Tam, P. Lavin, M. Fiorentino, G. F. Draetta, J. M. Jessup, and M. Pagano 1997. Increased proteosome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat. Med. 3: 231–234.
   PubMed Web of Science ®Google Scholar
• Lukas, J., J. Bartkova, and J. Bartek 1996. Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D–cyclin-dependent kinase–pRb-controlled G1 checkpoint. Mol. Cell. Biol. 16: 6917–6925.
   PubMed Web of Science ®Google Scholar
• Lukas, J., T. Herzinger, K. Hansen, M. C. Moroni, D. Resnitzky, K. Helin, S. I. Reed, and J. Bartek 1997. Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev. 11: 1479–1492.
   PubMed Web of Science ®Google Scholar
• Lundberg, A. S., and R. A. Weinberg 1998. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18: 753–761.
   PubMed Web of Science ®Google Scholar
• Marshall, C. J. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179–185.
   PubMed Web of Science ®Google Scholar
• Marshall, C. J. 1997. Ras effectors. Curr. Opin. Cell Biol. 8: 197–204.
   Google Scholar
• Matsuoka, M., J.-Y. Kato, R. P. Fisher, D. O. Morgan, and C. J. Sherr 1994. Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase. Mol. Cell. Biol. 14: 7265–7275.
   PubMed Web of Science ®Google Scholar
• Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J.-Y. Kato 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14: 2066–2076.
   PubMed Web of Science ®Google Scholar
• Meyerson, M., and E. Harlow 1994. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14: 2077–2086.
   PubMed Web of Science ®Google Scholar
• Mittnacht, S., H. Paterson, M. F. Olson, and C. J. Marshall 1997. Ras signalling is required for inactivation of tumour suppressor pRb cell-cycle control protein. Curr. Biol. 7: 219–221.
   PubMed Web of Science ®Google Scholar
• Morgenstern, J. P., and H. Land 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging line. Nucleic Acids Res. 18: 3587–3596.
   PubMed Web of Science ®Google Scholar
• Mulcahy, L. S., M. R. Smith, and D. W. Stacey 1985. Requirement for ras proto-oncogene function during serum-stimulated growth of NIH3T3 cells. Nature 313: 241–243.
   PubMed Web of Science ®Google Scholar
• Nakanashi, M., G. R. Adami, R. S. Robetorye, A. Noda, S. F. Venable, D. Dimitrov, O. M. Pereira-Smith, and J. R. Smith 1995. Exit from G0 and entry into the cell cycle of cells expressing p21Sdi1 antisense RNA. Proc. Natl. Acad. Sci. USA 92: 4352–4356.
   PubMedGoogle Scholar
• Neuman, E., M. H. Ladha, N. Lin, T. M. Upton, S. J. Miller, J. DiRenzo, R. G. Pestell, P. W. Hinds, S. F. Dowdy, M. Brown, and M. E. Ewen 1997. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol. Cell. Biol. 17: 5338–5347.
   PubMed Web of Science ®Google Scholar
• Noda, A., Y. Ning, S. F. Venable, O. M. Pereira-Smith, and J. R. Smith 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211: 90–98.
   PubMed Web of Science ®Google Scholar
• Nourse, J., E. Firpo, W. M. Flanagan, S. Coats, K. Polyak, M. H. Lee, J. Massague, G. R. Crabtree, and J. M. Roberts 1994. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372: 570–573.
   PubMed Web of Science ®Google Scholar
• Ohtsubo, M., and J. M. Roberts 1993. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 259: 1908–1912.
   PubMed Web of Science ®Google Scholar
• Ohtsubo, M., A. M. Theodoras, J. Schumacher, J. M. Roberts, and M. Pagano 1995. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell. Biol. 15: 2612–2624.
   PubMed Web of Science ®Google Scholar
• Okuda, K., T. J. Ernst, and J. D. Griffin 1994. Inhibition of p21ras activation blocks proliferation but not differentiation of interleukin-3-dependent myeloid cells. J. Biol. Chem. 269: 24602–24607.
   PubMed Web of Science ®Google Scholar
• Olson, M. F., H. F. Paterson, and C. J. Marshall 1998. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1. Nature 394: 295–299.
   PubMed Web of Science ®Google Scholar
• Pages, G., P. Lenorman, G. L’Allemain, J.-C. Chambard, S. Meloche, and J. Pouysségur 1993. Mitogen-activated protein kinase p42mapk and p44mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. USA 90: 8319–8323.
   PubMed Web of Science ®Google Scholar
• Pardee, A. B. 1974. A restriction point for control of normal animal cell proliferation. Proc. Natl. Acad. Sci. USA 71: 1286–1290.
   PubMed Web of Science ®Google Scholar
• Pardee, A. B. 1989. G1 events and regulation of cell proliferation. Science 246: 603–608.
   PubMed Web of Science ®Google Scholar
• Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90: 8392–8396.
   PubMed Web of Science ®Google Scholar
• Peeper, D. S., T. M. Upton, M. H. Ladha, E. Neuman, J. Zalvide, R. Bernards, J. A. DeCaprio, and M. E. Ewen 1997. Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature 386: 177–181.
   PubMed Web of Science ®Google Scholar
• Polyak, K., J.-Y. Kato, M. J. Solomon, C. J. Sherr, J. Massague, J. M. Roberts, and A. Koff 1994. p27Kip1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8: 9–22.
   PubMed Web of Science ®Google Scholar
• Polyak, K., M.-H. Lee, H. Erdjument-Bromage, A. Koff, J. M. Roberts, P. Tempst, and J. Massague 1994. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signal. Cell 78: 59–66.
   PubMed Web of Science ®Google Scholar
• Porter, P. L., K. E. Malone, P. J. Heagerty, G. M. Alexander, L. A. Gatti, E. J. Firpo, and J. R. Daling 1997. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlates with survival in young breast cancer patients. Nat. Med. 3: 222–225.
   PubMed Web of Science ®Google Scholar
• Pronk, G. J., and J. L. Bos 1994. The role of p21ras in receptor tyrosine kinase signalling. Biochim. Biophys. Acta 1198: 131–147.
   PubMedGoogle Scholar
• Quelle, D. E., R. A. Ashmun, S. A. Shurtleff, J. Kato, D. Bar-Sagi, M. F. Roussel, and C. J. Sherr 1993. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev. 7: 1559–1571.
   PubMed Web of Science ®Google Scholar
• Resnitzky, D., and S. I. Reed 1995. Different roles for cyclins D1 and E in regulation of the G1-to-S transition. Mol. Cell. Biol. 15: 3463–3469.
   PubMed Web of Science ®Google Scholar
• Rivard, N., G. L’Allemain, J. Bartek, and J. Pouysségur 1996. Abrogation of p27Kip1 by cDNA antisense suppresses quiescence (G0 state) in fibroblasts. J. Biol. Chem. 271: 18337–18341.
   PubMed Web of Science ®Google Scholar
• Robbins, D. J., M. Cheng, E. Zhen, C. A. Vanderbilt, L. A. Feig, and M. H. Cobb 1992. Evidence for a Ras-dependent extracellular signal-related protein kinase (ERK) cascade. Proc. Natl. Acad. Sci. USA 89: 6924–6928.
   PubMedGoogle Scholar
• Sellers, W. R., and W. G. Kaelin 1996. RB as a modulator of transcription. Biochim. Biophys. Acta. 1288: M1–M5.
   PubMedGoogle Scholar
• Serrano, M., E. Gomez-Lohoz, R. A. DePinho, D. Beach, and D. Bar-Sagi 1995. Inhibition of Ras-induced proliferation and transformation by p16INK4. Science 267: 249–252.
   PubMed Web of Science ®Google Scholar
• Serrano, M., A. W. Lin, M. E. McCurrach, D. Beach, and S. W. Lowe 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593–602.
   PubMed Web of Science ®Google Scholar
• Sewing, A., B. Wiseman, A. LLoyd, and H. Land 1997. High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol. Cell. Biol. 17: 5588–5597.
   PubMed Web of Science ®Google Scholar
• Sheaff, R. J., M. Groudine, M. Gordon, J. M. Roberts, and B. E. Clurman 1997. Cyclin E-cdk2 is a regulator of p27Kip1. Genes Dev. 11: 1464–1478.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J. 1993. Mammalian G1 cyclins. Cell 73: 1059–1065.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79: 551–555.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J. 1996. Cancer cell cycles. Science 274: 1672–1677.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and J. M. Roberts 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9: 1149–1163.
   PubMed Web of Science ®Google Scholar
• Stacey, D. W., L. A. Feig, and J. B. Gibbs 1991. Dominant inhibitor Ras mutants selectively inhibit the activity of either cellular or oncogenic Ras. Mol. Cell. Biol. 11: 4053–4064.
   PubMedGoogle Scholar
• Stacey, D. W., and H. F. Kung 1984. Transformation of NIH 3T3 cells by microinjection of Ha-ras protein. Nature 310: 508–511.
   PubMed Web of Science ®Google Scholar
• Szeberenyi, J., H. Cai, and G. M. Cooper 1990. Effect of a dominant inhibitory Ha-ras mutation on neuronal differentiation of PC12 cells. Mol. Cell. Biol. 10: 5324–5332.
   PubMedGoogle Scholar
• Takuwa, N., and Y. Takuwa 1997. Ras activity late in G1 phase required for p27kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts. Mol. Cell. Biol. 17: 5348–5358.
   PubMed Web of Science ®Google Scholar
• Temin, H. 1971. Stimulation by serum of multiplication of stationary chicken cells. J. Cell. Physiol. 78: 161–170.
   PubMed Web of Science ®Google Scholar
• Terada, Y., M. Tatsuka, S. Jinno, and H. Okayama 1995. Requirement for tyrosine phosphorylation of Cdk4 in G1 arrest induced by ultraviolet radiation. Nature 376: 358–362.
   PubMed Web of Science ®Google Scholar
• Thomas, S. M., M. DeMarco, G. D’Arcangelo, S. Helegoua, and J. S. Brugge 1992. Ras is essential for nerve growth factor- and phorbol ester-induced tyrosine phosphorylation of MAP kinases. Cell 68: 1031–1040.
   PubMed Web of Science ®Google Scholar
• Toyoshima, H., and T. Hunter 1994. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78: 67–74.
   PubMed Web of Science ®Google Scholar
• van den Heuvel, S., and E. Harlow 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262: 2050–2054.
   PubMed Web of Science ®Google Scholar
• Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81: 323–330.
   PubMed Web of Science ®Google Scholar
• Winston, J., F. Dong, and W. J. Pledger 1996. Differential modulation of G1 cyclins and the cdk inhibitor p27Kip1 by platelet-derived growth factor and plasma factors in density-arrested fibroblasts. J. Biol. Chem. 271: 11253–11260.
   PubMedGoogle Scholar
• Winston, J. T., S. R. Coats, Y.-Z. Wang, and W. J. Pledger 1996. Regulation of the cell cycle machinery by oncogenic Ras. Oncogene 12: 127–134.
   PubMed Web of Science ®Google Scholar
• Wood, K. W., C. Sarnecki, T. M. Roberts, and J. Blenis 1992. ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK. Cell 68: 1041–1050.
   PubMed Web of Science ®Google Scholar
• Woods, D., D. Parry, H. Cherwinski, E. Bosch, E. Lees, and M. McMahon 1997. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol. Cell. Biol. 17: 5598–5611.
   PubMed Web of Science ®Google Scholar
• Zetterberg, A., O. Larsson, and K. G. Wiman 1995. What is the restriction point? Curr. Opin. Cell Biol. 7: 835–842.
   PubMed Web of Science ®Google Scholar
• Zhao, J., B. Dynlacht, T. Imai, T.-A. Hori, and E. Harlow 1998. Expression of NPAT, a novel substrate of cyclin E-cdk2, promotes S-phase entry. Genes Dev. 12: 456–461.
   PubMed Web of Science ®Google Scholar